MCL1 and cancer: Importantly, suppression of DUBs upstream of MCL-1 is an attractive approach by which MCL-1 levels could be decreased in cancers (Figure 3), although the principal enzymes responsible for MCL-1 stabilization are highly cell-type specific and dependent on the wider proteomic profile of the target cell [90].